<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38185377</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>165</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Long-Term Effects of COVID-19 on the Cardiopulmonary System in Adults and Children: Current Status and Questions to be Resolved by the National Institutes of Health Researching COVID to Enhance Recovery Initiative.</ArticleTitle><Pagination><StartPage>978</StartPage><EndPage>989</EndPage><MedlinePgn>978-989</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2023.12.030</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(24)00006-0</ELocationID><Abstract><AbstractText Label="TOPIC IMPORTANCE" NlmCategory="UNASSIGNED">Long COVID may occur in at least 10%&#xa0;of patients recovering from SARS-CoV-2 infection and often is associated with debilitating symptoms. Among the organ systems that might be involved in its pathogenesis, the respiratory and cardiovascular systems may be central to common symptoms seen in survivors of COVID-19, including fatigue, dyspnea, chest pain, cough, and exercise intolerance. Understand the exact symptomatology, causes, and effects of long COVID on the heart and lungs may help us to discover new therapies. To that end, the National Institutes of Health is sponsoring a national study population of diverse volunteers to support large-scale studies on the long-term effects of COVID-19.</AbstractText><AbstractText Label="REVIEW FINDINGS" NlmCategory="RESULTS">The National Institutes of Health Researching COVID to Enhance Recovery (RECOVER) initiative currently is recruiting participants in the United States to answer critical questions about long COVID. The study comprises adult and pediatric cohorts as well as an electronic health record cohort. Based on symptoms, individuals undergo prespecified medical testing to understand whether abnormalities can be detected and are followed up longitudinally. Herein, we outline current understanding of the clinical symptoms and pathophysiologic features of long COVID with respect to the cardiopulmonary system in adults and children and then determine how the clinical, electronic health record, and autopsy cohorts of the RECOVER initiative will attempt to answer the most pressing questions surrounding the long-term effects of COVID-19.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">Data generated from the RECOVER initiative will provide guidance about missing gaps in our knowledge about long COVID and how they might be filled by data gathered through the RECOVER initiative.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rischard</LastName><ForeName>Franz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Arizona, Tucson, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altman</LastName><ForeName>Natasha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szmuszkovicz</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, CA; Division of Cardiology, Keck School of Medicine of the University of Southern California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sciurba</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berman-Rosenzweig</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Columbia University School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Heart Center, Ann &amp; Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnan</LastName><ForeName>Sankaran</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Boston Children's Health Physicians, New York Medical College, Valhalla, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truong</LastName><ForeName>Ngan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Radiology, Keck School of Medicine of the University of Southern California, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finn</LastName><ForeName>Aloke V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>CVPath Institute, Gaithersburg, University of Maryland School of Medicine, Baltimore, MD; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. Electronic address: afinn@cvpath.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Researching COVID to Enhance Recovery Cardiopulmonary Committee</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">heart</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">lungs</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword></KeywordList><CoiStatement>Financial/Nonfinancial Disclosures None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>7</Day><Hour>19</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38185377</ArticleId><ArticleId IdType="pmc">PMC11026169</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2023.12.030</ArticleId><ArticleId IdType="pii">S0012-3692(24)00006-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934&#x2013;1946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein D.S. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. 2021;18(4):508&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7729277</ArticleId><ArticleId IdType="pubmed">33316414</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow P., O&#x2019;Sullivan O., Houston A., et al. Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart Rhythm. 2022;19(4):613&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8656177</ArticleId><ArticleId IdType="pubmed">34896622</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavelle M.P., Desai A.D., Wan E.Y. Arrhythmias in the COVID-19 patient. Heart Rhythm. 2022;3(1):8&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758199</ArticleId><ArticleId IdType="pubmed">35043098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingul C.B., Grimsmo J., Mecinaj A., et al. Cardiac dysfunction and arrhythmias 3&#xa0;months after hospitalization for COVID-19. J&#xa0;Am Heart Assoc. 2022;11(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238505</ArticleId><ArticleId IdType="pubmed">35048715</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P.P., Blet A., Smyth D., Li H. The science underlying COVID-19. Circulation. 2020;142(1):68&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini P.E., Laghi-Pasini F., Boutjdir M., Capecchi P.L. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019;19(1):63&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30552387</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S., Tong M.S., Borchers J., et al. Cardiovascular magneticresonance findings in competitive athletes recovering from COVID-19 infection [published correction appears in JAMA Cardiol. 2021;6(1):123] JAMA Cardiol. 2021;6(1):116&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D., Fitzek A., Br&#xe4;uninger H., et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5(11):1281&#x2013;1285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W.-C., FitzGerald G.A. COVID-19, microangiopathy, hemostatic activation, and complement. J&#xa0;Clin Invest. 2020;130(8):3950&#x2013;3953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410042</ArticleId><ArticleId IdType="pubmed">32459663</ArticleId></ArticleIdList></Reference><Reference><Citation>Bristow M.R., Zisman L.S., Altman N.L., et al. Dynamic regulation of SARS-Cov-2 binding and cell entry mechanisms in remodeled human ventricular myocardium. JACC Basic Transl Sci. 2020;5(9):871&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314447</ArticleId><ArticleId IdType="pubmed">32838074</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M.K.-W.H., Schroeder S., Kr&#xfc;ger N., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;280.E8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey A.L.D.O., Greenberg L., Bredemeyer A.L., et al. SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis. JACC Basic Transl Sci. 2021;6(4):331&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7909907</ArticleId><ArticleId IdType="pubmed">33681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M.K., Zidar D.A., Bristow M.R., et al. COVID-19 and cardiovascular disease. Circ Res. 2021;128(8):1214&#x2013;1236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M., Reistam U., Fedorowski A., et al. Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med. 2021;134(12):1451&#x2013;1456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356730</ArticleId><ArticleId IdType="pubmed">34390682</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Pinto M.D., Borelli J.L., et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: looking for clarity in the haze of the pandemic. Clin Nurs Res. 2022;31(8):1390&#x2013;1398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Network Open. 2021;4(10) e2128568-e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., et al. COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar M.P., Tunnicliffe E.M., Petousi N., et al. Symptom persistence despite improvement in cardiopulmonary health&#x2014;insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine. 2021;41</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8527025</ArticleId><ArticleId IdType="pubmed">34693230</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall K.J., Mukherjee B., Castanheira A.M., et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18(5):799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., Rosas I.O., Singer M. Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity. Intensive Care Med. 2022;48(12):1803&#x2013;1806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453725</ArticleId><ArticleId IdType="pubmed">36074167</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri L., Moss S., Khan F.A., et al. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Thorax. 2023;78(2):191&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">35338102</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka K.E., Perry W., Huang T., Farver C.F., Myers J.L. Usual interstitial pneumonia is the most common finding in surgical lung biopsies from patients with persistent interstitial lung disease following infection with SARS-CoV-2. EClinicalMedicine. 2021;42</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609167</ArticleId><ArticleId IdType="pubmed">34841234</ArticleId></ArticleIdList></Reference><Reference><Citation>Culebras M., Loor K., Sansano I., et al. Histological findings in transbronchial cryobiopsies obtained from patients after COVID-19. Chest. 2022;161(3):647&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8464080</ArticleId><ArticleId IdType="pubmed">34582842</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela C., Waterer G., Raghu G. Interstitial lung disease before and after COVID-19: a double threat? Eur Respir J. 2021;58(6):2101956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8637181</ArticleId><ArticleId IdType="pubmed">34857587</ArticleId></ArticleIdList></Reference><Reference><Citation>McFadyen J.D., Stevens H., Peter K. The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications. Circ Res. 2020;127(4):571&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386875</ArticleId><ArticleId IdType="pubmed">32586214</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel B.V., Arachchillage D.J., Ridge C.A., et al. Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations. Am J Respir Crit Care Med. 2020;202(5):690&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462405</ArticleId><ArticleId IdType="pubmed">32667207</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E., Corsetti G., Romano C., et al. Serum metabolic profile in patients with long-COVID (PASC) syndrome: clinical implications. Front Med (Lausanne) 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20(1):172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannis D., Allen S.L., Tsang J., et al. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021;137(20):2838&#x2013;2847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032474</ArticleId><ArticleId IdType="pubmed">33824972</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparisi A., Ladron R., Ybarra-Falcon C., Tobar J., San Roman J.A. Exercise intolerance in post-acute sequelae of COVID-19 and the value of cardiopulmonary exercise testing&#x2014;a mini-review. Front Med (Lausanne) 2022;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352932</ArticleId><ArticleId IdType="pubmed">35935782</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A., Mahsouli A., Liistro G., et al. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir Med. 2021;181</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="pubmed">33839588</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo R.F., Mondoni M., Parazzini E.M., et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021;58(2):2100870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082950</ArticleId><ArticleId IdType="pubmed">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparisi A., Ybarra-Falcon C., Garcia-Gomez M., et al. Exercise ventilatory inefficiency in post-COVID-19 syndrome: insights from a prospective evaluation. J Clin Med. 2021;10(12):2591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8230788</ArticleId><ArticleId IdType="pubmed">34208271</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite J., Balagny P., Arnoult F., et al. Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors. Eur Respir J. 2021;58(2):2101578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8361302</ArticleId><ArticleId IdType="pubmed">34385265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini D.M., Brunjes D.L., Lala A., Trivieri M.G., Contreras J.P., Natelson B.H. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. 2021;9(12):927&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2022;161(1):54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pinto Pereira S.M., Shafran R., et al. Physical and mental health 3&#xa0;months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022;6(4):230&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan D., Kim J.H., Elliott M.D., et al. Screening of potential cardiac involvement in competitive athletes recovering from COVID-19: an expert consensus statement. JACC Cardiovasc Imaging. 2020;13(12):2635&#x2013;2652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598679</ArticleId><ArticleId IdType="pubmed">33303102</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels C.J., Rajpal S., Greenshields J.T., et al. Big Ten COVID-19 Cardiac Registry Investigators, Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol. 2021;6(9):1078&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark D.E., Parikh A., Dendy J.M., et al. COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR) Circulation. 2021;143(6):609&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864610</ArticleId><ArticleId IdType="pubmed">33332151</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito D., Meester S., Yanamala N., et al. High prevalence of pericardial involvement in college student athletes recovering from COVID-19. JACC Cardiovasc Imaging. 2021;14(3):541&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7641597</ArticleId><ArticleId IdType="pubmed">33223496</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.C., Morphew T., Ehwerhemuepha L., Galant S.P. COVID-19 infection may trigger poor asthma control in children. J Allergy Clin Immunol Pract. 2022;10(7):1913&#x2013;1915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9040415</ArticleId><ArticleId IdType="pubmed">35487371</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber C.N., Patel R.S., Trachtman R., et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C) Cell. 2020;183(4):982&#x2013;995 e914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489877</ArticleId><ArticleId IdType="pubmed">32991843</ArticleId></ArticleIdList></Reference><Reference><Citation>Belay E.D., Abrams J., Oster M.E., et al. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic. JAMA Pediatr. 2021;175(8):837&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8025123</ArticleId><ArticleId IdType="pubmed">33821923</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne A.B., Gilani Z., Godfred-Cato S., et al. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw Open. 2021;4(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193431</ArticleId><ArticleId IdType="pubmed">34110391</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhedin S., Lundholm C., Horne A., et al. Risk factors for multisystem inflammatory syndrome in children&#x2014;a population-based cohort study of over 2 million children. Lancet Reg Health Eur. 2022;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9353212</ArticleId><ArticleId IdType="pubmed">35945929</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsubara D., Chang J., Kauffman H.L., et al. Longitudinal assessment of cardiac outcomes of multisystem inflammatory syndrome in children associated with COVID-19 infections. J&#xa0;Am Heart Assoc. 2022;11(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238494</ArticleId><ArticleId IdType="pubmed">35043684</ArticleId></ArticleIdList></Reference><Reference><Citation>DiLorenzo M.P., Farooqi K.M., Shah A.M., et al. Ventricular function and tissue characterization by cardiac magnetic resonance imaging following hospitalization for multisystem inflammatory syndrome in children: a prospective study. Pediatr Radiol. 2023;53(3):394&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9579624</ArticleId><ArticleId IdType="pubmed">36255453</ArticleId></ArticleIdList></Reference><Reference><Citation>Enner S., Shah Y.D., Ali A., et al. Patients diagnosed with multisystem inflammatory syndrome in children have persistent neurologic, sleep, and psychiatric symptoms after hospitalization. J&#xa0;Child Neurol. 2022;37(5):426&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">35072534</ArticleId></ArticleIdList></Reference><Reference><Citation>Penner J., Abdel-Mannan O., Grant K., et al. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health. 2021;5(7):473&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">34043958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>